Inspire Medical Systems, INC. (INSP) — SEC Filings

Q: What are the key financial highlights for Inspire Medical Systems, INC.?

Key financial highlights for Inspire Medical Systems, INC. are extracted from the most recent 10-K or 10-Q filings, including revenue, net income, EPS, debt-to-equity, cash position, and operating margin.

Q: Who are the key executives at Inspire Medical Systems, INC.?

Key executives at Inspire Medical Systems, INC. are identified from SEC filings including 10-K annual reports, proxy statements, and insider trade forms.

Q: What are the main risk factors for Inspire Medical Systems, INC. stock?

Risk factors for Inspire Medical Systems, INC. (INSP) are assessed from SEC filings using AI analysis. Each filing is categorized as high, medium, or low risk based on disclosed risk factors and financial indicators.

Q: What are recent predictions and forward guidance from Inspire Medical Systems, INC.?

Forward-looking statements and predictions from Inspire Medical Systems, INC. are extracted from SEC filings including earnings reports, annual reports, and current event filings.

Latest SEC filings for Inspire Medical Systems, INC.. Recent 8-K filing on Nov 17, 2025. AI-decoded analysis of earnings, risk factors, and insider trades.

View Inspire Medical Systems, INC. on SEC EDGAR

Overview

Inspire Medical Systems, INC. (INSP) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Nov 17, 2025: Inspire Medical Systems, Inc. filed an 8-K on November 17, 2025, to report other events. The filing does not contain specific details about the nature of these events, dollar amounts, or new agreements.

Sentiment Summary

Across 30 filings, the sentiment breakdown is: 2 bullish, 1 bearish, 27 neutral. The dominant filing sentiment for Inspire Medical Systems, INC. is neutral.

Filing Type Overview

Inspire Medical Systems, INC. (INSP) has filed 15 8-K, 5 10-Q, 2 DEF 14A, 2 10-K, 6 SC 13G/A with the SEC between Jan 2024 to Nov 2025.

Filings by Year

2025 · 2024

Recent Filings (30)

Inspire Medical Systems Files 8-K — 8-K · Nov 17, 2025 Risk: medium
Inspire Medical Systems, Inc. filed an 8-K on November 17, 2025, to report other events. The filing does not contain specific details about the nature of these
Inspire Medical's Q3 Net Income Halves Amid Soaring SG&A Costs — 10-Q · Nov 3, 2025 Risk: medium
Inspire Medical Systems, Inc. (INSP) reported revenue of $224.5 million for the three months ended September 30, 2025, an increase from $203.2 million in the sa
Inspire Medical Systems Files 8-K — 8-K · Oct 10, 2025 Risk: low
Inspire Medical Systems, Inc. filed an 8-K on October 10, 2025, reporting information under Regulation FD Disclosure and Financial Statements and Exhibits. The
Inspire Medical Systems Files 8-K on Officer/Director Changes — 8-K · Aug 26, 2025 Risk: medium
Inspire Medical Systems, Inc. filed an 8-K on August 26, 2025, reporting on events as of August 22, 2025. The filing covers the departure of directors or certai
Inspire Medical Systems Files 8-K — 8-K · Aug 11, 2025 Risk: low
Inspire Medical Systems, Inc. filed an 8-K on August 11, 2025, reporting other events and financial statements/exhibits. The filing does not detail specific tra
Inspire Medical Soars: Q2 Revenue Up 26.5%, Swings to Profit — 10-Q · Aug 4, 2025 Risk: medium
Inspire Medical Systems, Inc. reported robust financial performance for the second quarter ended June 30, 2025, with revenue reaching $192.5 million, marking a
Inspire Medical Systems Files 8-K — 8-K · Jun 13, 2025 Risk: low
Inspire Medical Systems, Inc. filed an 8-K on June 13, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the
10-Q Filing — 10-Q · May 5, 2025
Inspire Medical Systems Files 2025 Proxy Statement — DEF 14A · Mar 18, 2025 Risk: low
Inspire Medical Systems, Inc. filed its definitive proxy statement (DEF 14A) on March 18, 2025, for its annual meeting on May 1, 2025. The filing details inform
Inspire Medical Systems Files 2024 Annual Report — 10-K · Feb 10, 2025 Risk: low
Inspire Medical Systems, Inc. filed its annual report for the fiscal year ended December 31, 2024. The company is incorporated in Delaware and headquartered in
Inspire Medical Systems Files 8-K — 8-K · Jan 13, 2025 Risk: low
Inspire Medical Systems, Inc. filed an 8-K on January 13, 2025, reporting on its results of operations and financial condition. The filing also includes Regulat
Inspire Medical Systems to Acquire Advanced Laryngeal Technologies — 8-K · Nov 12, 2024 Risk: medium
Inspire Medical Systems, Inc. announced on November 8, 2024, that it has entered into a definitive agreement to acquire all of the outstanding equity interests
SC 13G/A Filing — SC 13G/A · Nov 12, 2024
Inspire Medical Systems Files Q3 2024 10-Q — 10-Q · Nov 4, 2024 Risk: medium
Inspire Medical Systems, Inc. filed its 10-Q for the period ending September 30, 2024. The filing covers the third quarter and the first nine months of the fisc
SC 13G/A Filing — SC 13G/A · Oct 7, 2024
SC 13G/A Filing — SC 13G/A · Oct 4, 2024
Inspire Medical Systems Files 8-K — 8-K · Aug 6, 2024 Risk: low
Inspire Medical Systems, Inc. filed an 8-K on August 6, 2024, reporting on results of operations, financial condition, and other events. The filing includes fin
Inspire Medical Systems Files 8-K — 8-K · Aug 2, 2024 Risk: low
Inspire Medical Systems, Inc. filed an 8-K on August 2, 2024, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain spec
Inspire Medical Systems Files 8-K on Financials — 8-K · Jul 29, 2024 Risk: low
Inspire Medical Systems, Inc. filed an 8-K on July 29, 2024, reporting on its results of operations and financial condition. The filing includes financial state
Inspire Medical Systems Appoints New Chief Medical Officer — 8-K · Jul 22, 2024 Risk: low
Inspire Medical Systems, Inc. announced on July 18, 2024, the appointment of Dr. Steven J. Shulman as Chief Medical Officer. Dr. Shulman previously served as Ch
Inspire Medical Systems Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 7, 2024 Risk: low
Inspire Medical Systems, Inc. (INSP) filed a Quarterly Report (10-Q) with the SEC on May 7, 2024. Inspire Medical Systems, Inc. filed a 10-Q report for the peri
Inspire Medical Systems Files 2024 Proxy Statement — DEF 14A · Mar 19, 2024 Risk: low
Inspire Medical Systems, Inc. filed a DEF 14A proxy statement on March 19, 2024, for its annual meeting on May 2, 2024. The filing details the company's governa
SC 13G/A Filing — SC 13G/A · Feb 13, 2024
Inspire Medical Systems, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 9, 2024 Risk: medium
Inspire Medical Systems, Inc. (INSP) filed a Annual Report (10-K) with the SEC on February 9, 2024. Inspire Medical Systems, Inc. filed its annual report on For
FMR LLC & Abigail Johnson Hold 11.033% Stake in Inspire Medical — SC 13G/A · Feb 9, 2024 Risk: low
FMR LLC, a major investment firm, and its principal owner, Abigail P. Johnson, have updated their ownership stake in Inspire Medical Systems, Inc. As of Decembe
Inspire Medical Systems Sets Q4/FY23 Earnings Call for Feb 20 — 8-K · Feb 6, 2024
Inspire Medical Systems, Inc. filed an 8-K on February 6, 2024, to announce the date of its upcoming earnings call. The company will release its fourth quarter
Inspire Medical Systems 8-K: Officer/Director Changes, Comp Arrangements — 8-K · Feb 5, 2024
Inspire Medical Systems, Inc. filed an 8-K on February 5, 2024, reporting events that occurred on January 30, 2024. This filing primarily concerns the departure
BlackRock Updates Passive Stake in Inspire Medical Systems — SC 13G/A · Jan 29, 2024
BlackRock Inc. filed an amended SC 13G/A on January 29, 2024, indicating its ownership of Inspire Medical Systems, Inc. common stock as of December 31, 2023. Th
Inspire Medical Systems Reports Officer/Director Changes — 8-K · Jan 26, 2024
Inspire Medical Systems, Inc. filed an 8-K on January 26, 2024, reporting an event that occurred on January 22, 2024. This filing indicates changes related to '
Inspire Medical Systems Files 8-K on Operations & Financial Condition — 8-K · Jan 8, 2024
Inspire Medical Systems, Inc. filed an 8-K on January 8, 2024, to report on its results of operations and financial condition, as well as Regulation FD disclosu

Risk Profile

Risk Assessment: Of INSP's 20 recent filings, 0 were flagged as high-risk, 7 as medium-risk, and 13 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Key financial metrics from Inspire Medical Systems, INC.'s most recent 10-Q filing (Nov 3, 2025):

Revenue: $224.5M
Net Income: $9.9M
EPS: $0.34
Cash Position: $112.8M
Operating Margin: 4.3%
Total Assets: $807.7M
Total Debt: $141.3M

Key Executives

Dr. Steven J. Shulman
Abigail P. Johnson

Industry Context

Inspire Medical Systems operates in the rapidly evolving medical technology sector, specifically addressing the large and growing market for sleep apnea treatment. The company's neurostimulation approach offers a unique alternative to traditional CPAP machines. Key industry trends include increasing adoption of minimally invasive procedures, demand for innovative chronic disease management solutions, and a competitive landscape with established players and emerging technologies.

Top Tags

8-K (3) · Medical Devices (3) · compensation (3) · filing (3) · medical-devices (3) · financial-condition (3) · Sleep Apnea (2) · Profitability (2) · corporate-disclosure (2) · 8-k (2)

Key Numbers

Q3 2025 Revenue: $224.5M — Increased from $203.2M in Q3 2024, showing 10.5% growth.
Q3 2025 Net Income: $9.9M — Decreased significantly from $18.5M in Q3 2024, a 46.4% decline.
Q3 2025 Selling, General and Administrative Expenses: $158.9M — Increased from $130.4M in Q3 2024, representing a 21.8% rise.
Cash and Cash Equivalents: $112.8M — Decreased from $150.2M at December 31, 2024, a 24.8% reduction.
Inventories, net: $141.8M — Increased from $80.1M at December 31, 2024, a 77.0% increase.
Share Repurchase of Common Stock: $125.0M — Amount spent during the nine months ended September 30, 2025.
Basic Net Income Per Share (Q3 2025): $0.34 — Down from $0.62 in Q3 2024.
Q2 2025 Revenue: $192.5M — Increased 26.5% from Q2 2024
Q2 2025 Net Income: $15.3M — Swung from a $2.1M net loss in Q2 2024
Q2 Revenue Growth: 26.5% — Year-over-year increase for Q2 2025
Six-Month Revenue Growth: 28.1% — Year-over-year increase for the first half of 2025
Gross Margin: 83.9% — Achieved in Q2 2025, indicating strong profitability per sale
U.S. Revenue Q2 2025: $183.4M — Increased 27.1% from Q2 2024, showing strong domestic growth
Q2 2025 Operating Expenses: $146.7M — Increased 14.2% from Q2 2024, driven by personnel and clinical costs
Public Document Count: 57 — Indicates the number of documents included in the filing package.

Forward-Looking Statements

{"claim":"FMR LLC will maintain a significant stake in Inspire Medical Systems, Inc. for the foreseeable future.","entity":"FMR LLC","targetDate":"2025-02-09","confidence":"high"}
{"claim":"The continued institutional ownership by FMR LLC could positively influence investor sentiment towards Inspire Medical Systems, Inc.","entity":"Inspire Medical Systems, Inc.","targetDate":"2024-08-09","confidence":"medium"}

Related Companies

RMD · PHG

Frequently Asked Questions

What are the latest SEC filings for Inspire Medical Systems, INC. (INSP)?

Inspire Medical Systems, INC. has 30 recent SEC filings from Jan 2024 to Nov 2025, including 15 8-K, 6 SC 13G/A, 5 10-Q. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of INSP filings?

Across 30 filings, the sentiment breakdown is: 2 bullish, 1 bearish, 27 neutral. The dominant sentiment is neutral.

Where can I find Inspire Medical Systems, INC. SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Inspire Medical Systems, INC. (INSP) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Inspire Medical Systems, INC.?

Key financial highlights from Inspire Medical Systems, INC.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.

What is the investment thesis for INSP?

The investment thesis for INSP includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Inspire Medical Systems, INC.?

Key executives identified across Inspire Medical Systems, INC.'s filings include Dr. Steven J. Shulman, Abigail P. Johnson.

What are the main risk factors for Inspire Medical Systems, INC. stock?

Of INSP's 20 assessed filings, 0 were flagged high-risk, 7 medium-risk, and 13 low-risk.

What are recent predictions and forward guidance from Inspire Medical Systems, INC.?

Recent forward-looking statements from Inspire Medical Systems, INC. include guidance on {"claim":"FMR LLC will maintain a significant stake in Inspire Medical Systems, Inc. for the foreseeable future.","entit and 1 other predictions.